表紙
市場調查報告書

細胞培養的全球市場預測 2024年:生物醫藥品、治療 (治療性蛋白質、疫苗生產),診斷,藥物篩檢、開發,幹細胞研究,組織工程、再生醫療

Cell Culture Market by Product (Consumables (Media, FBS), Equipment (Bioreactor, Centrifuge, Incubator, Microscope, Autoclave)), Application (Stem Cell, Vaccines, Therapeutic proteins), End User (Pharma, Research Institutes) - Global Forecast to 2024

出版商 MarketsandMarkets 商品編碼 308211
出版日期 內容資訊 英文 235 Pages
訂單完成後即時交付
價格
Back to Top
細胞培養的全球市場預測 2024年:生物醫藥品、治療 (治療性蛋白質、疫苗生產),診斷,藥物篩檢、開發,幹細胞研究,組織工程、再生醫療 Cell Culture Market by Product (Consumables (Media, FBS), Equipment (Bioreactor, Centrifuge, Incubator, Microscope, Autoclave)), Application (Stem Cell, Vaccines, Therapeutic proteins), End User (Pharma, Research Institutes) - Global Forecast to 2024
出版日期: 2019年07月08日內容資訊: 英文 235 Pages
簡介

全球細胞培養市場在2019年∼2024年間,預測將以12.7%的年複合成長率 (CAGR) 發展,從2019年的160億美元,成長到2024年292億美元的規模。該市場,由於細胞培養型疫苗的優點相關認識高漲,對單株抗體 (mAb) 的需求增加,細胞培養研究的資金,單回使用技術偏好的高漲,個人化醫療的關注高漲,及先進細胞培養產品的銷售等,而大幅度成長。可是,對細胞生物學研究高額的成本及細胞為基礎的研究活動的適當基礎設施的不足,成為抑制該市場成長的主要原因。

本報告提供全球細胞培養的市場相關調查,市場定義和概要,市場成長的影響因素及市場機會分析,各設備、消耗品、用途、終端用戶、地區的主要趨勢與市場規模的變化與預測,競爭環境與市場佔有率,主要企業的簡介等系統性資訊。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 細胞培養:市場概要
  • 歐洲的細胞培養容器市場佔有率:各終端用戶、各國
  • 細胞培養血清、培養基、試劑市場:各類型
  • 細胞培養市場:各用途
  • 細胞培養市場:各產品
  • 細胞培養市場地區概要

第5章 市場概要

  • 簡介
  • 市場動態
    • 促進要素
    • 阻礙要素
    • 機會

第6章 細胞培養市場:各產品

  • 簡介
  • 消耗品
    • 血清、培養基、試劑
    • 容器
      • 轉瓶/洛氏瓶
      • 細胞工廠系統/細胞堆疊
      • 燒瓶
      • 培養皿
    • 生物反應器配件
  • 設備
    • 支援設備
      • 過濾系統
      • 電池單元計數器
      • 二氧化碳培養器
      • 離心機
      • 高壓釜
      • 顯微鏡
      • 生物安全櫃
      • 其他
    • 生物反應器
      • 傳統生物反應器
      • 單回使用生物反應器
    • 保存設備
      • 冰箱、冷凍庫
      • 低溫存儲系統

第7章 細胞培養市場:各用途

  • 簡介
  • 生物醫藥品、治療用途
    • 治療性蛋白質
    • 疫苗生產
  • 診斷
  • 藥物篩檢、開發
  • 幹細胞研究
  • 組織工程、再生醫療
  • 其他

第8章 細胞培養市場:各終端用戶

  • 簡介
  • 醫藥品、生物科技企業
  • 醫院、診斷實驗室
  • 研究機關
  • 細胞庫

第9章 細胞培養市場:各地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他的歐洲
  • 亞洲
    • 日本
    • 中國
    • 印度
    • 其他的亞太地區
  • 其他 (ROW)

第10章 競爭環境

  • 概要
  • 市場佔有率分析
  • 競爭模式
  • 競爭領導製圖

第11章 企業簡介

  • BECTON, DICKINSON AND COMPANY
  • CELLGENIX
  • CORNING
  • DANAHER
  • EPPENDORF
  • FUJIFILM IRVINE SCIENTIFIC (Fujifilm 收購)
  • GE HEALTHCARE (A SUBSIDIARY OF GENERAL ELECTRIC COMPANY)
  • HI-MEDIA LABORATORIES
  • INVIVOGEN
  • LONZA GROUP AG
  • MERCK KGAA
  • MILTENYI BIOTEC
  • PROMOCELL
  • SARTORIUS AG
  • THERMO FISHER SCIENTIFIC

第12章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: BT 2561

"Increasing funding for cell-based research, growing benefits of the cell culture-based vaccines, and rising demand for monoclonal antibodies are expected to drive the overall growth of the cell culture market."

The cell culture market is expected to reach USD 29.2 billion by 2024 from USD 16.0 billion in 2019, at a CAGR of 12.7% during the forecast period. This market is experiencing significant growth due to the growing awareness about the benefits of cell culture-based vaccines, increasing demand for monoclonal antibodies (mAbs), funding for cell-based research, growing preference for single-use technologies, growing focus on personalized medicine, and the launch of advanced cell culture products. On the other hand, the high cost of cell biology research and the lack of proper infrastructure for cell-based research activities are the major factors restraining the growth of this market.

"Pharmaceutical and biotechnology companies are expected to dominate the market during the forecast period."

Based on end user, the cell culture market is segmented into research institutes, pharmaceutical & biotechnology companies, cell banks, and hospitals & diagnostic laboratories. In 2018, pharmaceutical and biotechnology companies accounted for the largest share of the cell culture market. The growing use of single-use technologies, increasing number of regulatory approvals for cell culture-based vaccines, and the presence of a large number of pharmaceutical players in this market are some of the factors driving the cell culture market for pharmaceutical and biotechnology companies.

"Biopharmaceutical production to witness the highest growth in the cell culture market."

Based on application, the cell culture market is categorized into biopharmaceutical production, stem cell research, diagnostics, drug discovery & development, tissue engineering & regenerative medicine, and other applications. The biopharmaceutical production segment is also expected to grow at the highest CAGR during the forecast period. The high growth of this segment is attributed to the commercial expansion of major pharmaceutical companies, growing regulatory approvals for the production of cell culture-based vaccines, and increasing demand for monoclonal antibodies (mAbs).

"North America to dominate the market during the forecast period."

Geographically, the cell culture market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2018, North America accounted for the largest share of the cell culture market. The growing regulatory approvals for cell culture-based vaccines, technological advancements, growth in the biotechnology and pharmaceutical industries, higher investments in cell-based research, rising incidence of diseases such as cancer, strong government support, and conferences and symposiums that create awareness on the latest trends in cell culture technology are the key factors driving the growth of the cell culture market in North America.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type - Tier 1: 36%, Tier 2: 45%, and Tier 3: 19%
  • By Designation - C-level: 33%, D-level: 40%, and Others: 27%
  • By Region - North America: 36%, Europe: 28%, Asia Pacific: 19%, Rest of the World: 17%

List of Companies Profiled in the Report:

  • Thermo Fisher Scientific (US)
  • Merck KGaA (Germany)
  • GE Healthcare (US)
  • Lonza (Switzerland)
  • Becton, Dickinson and Company (US)
  • Corning Incorporated (US)
  • Eppendorf AG (Germany)
  • HiMedia Laboratories (India)
  • Sartorius AG (Germany)
  • PromoCell GmbH (Germany)
  • Danaher Corporation (US)
  • FUJIFILM Irvine Scientific (US)
  • InvivoGen (US)
  • CellGenix GmbH (Germany)
  • Miltenyi Biotec (Germany)

Research Coverage:

This report provides a detailed picture of the global cell culture market. It aims at estimating the size and future growth potential of the market across different segments, such as product, application, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall cell culture market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the pulse of the market and provide them with information on the key market drivers, restraints, and opportunities.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 LIMITATION
  • 1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
  • 2.2 SECONDARY DATA
    • 2.2.1 SECONDARY SOURCE
  • 2.3 PRIMARY DATA
    • 2.3.1 KEY DATA FROM PRIMARY SOURCES
  • 2.4 MARKET SIZE ESTIMATION
  • 2.5 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.6 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 CELL CULTURE: MARKET OVERVIEW
  • 4.2 ASIA PACIFIC: CELL CULTURE MARKET SHARE, BY END USER AND COUNTRY (2019)
  • 4.3 CELL CULTURE SERA, MEDIA, & REAGENTS MARKET, BY TYPE (USD BILLION)
  • 4.4 CELL CULTURE MARKET, BY APPLICATION, 2019 VS. 2024 (USD BILLION)
  • 4.5 CELL CULTURE MARKET, BY PRODUCT, 2019 VS. 2024 (USD BILLION)
  • 4.6 GEOGRAPHICAL SNAPSHOT OF THE CELL CULTURE MARKET

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 MARKET DRIVERS
      • 5.2.1.1 Growing awareness about the benefits of cell culture-based vaccines
      • 5.2.1.2 Increasing demand for monoclonal antibodies
      • 5.2.1.3 Funding for cell-based research
      • 5.2.1.4 Growing preference for single-use technologies
      • 5.2.1.5 Launch of advanced cell culture products
      • 5.2.1.6 Growing focus on personalized medicine
    • 5.2.2 MARKET RESTRAINTS
      • 5.2.2.1 High cost of cell biology research
      • 5.2.2.2 Lack of infrastructure for cell-based research in emerging economies
    • 5.2.3 MARKET OPPORTUNITIES
      • 5.2.3.1 Growing demand for 3D cell culture
      • 5.2.3.2 Increased risk of pandemics and communicable diseases
      • 5.2.3.3 Emerging economies

6 CELL CULTURE MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
  • 6.2 CONSUMABLES
    • 6.2.1 SERA, MEDIA, AND REAGENTS
      • 6.2.1.1 Media
        • 6.2.1.1.1 Serum-free media
        • 6.2.1.1.1.1 Lack of sera eliminates the risk of contamination by viruses
        • 6.2.1.1.2 Classical media & salts
        • 6.2.1.1.2.1 Classical media is commonly used in diagnostics and manufacturing
        • 6.2.1.1.3 Stem cell culture media
        • 6.2.1.1.3.1 Stem cell culture media will witness the highest growth in the APAC market
        • 6.2.1.1.4 Specialty media
        • 6.2.1.1.4.1 Specialty media is suitable for specific, selective cell types
      • 6.2.1.2 Reagents
        • 6.2.1.2.1 Supplements & growth factors
        • 6.2.1.2.1.1 Supplements such as amino acids play a key role in inducing cell growth
        • 6.2.1.2.2 Buffers & chemicals
        • 6.2.1.2.2.1 Chemical buffers are widely used, but are expensive and can be toxic
        • 6.2.1.2.3 Cell dissociation reagents
        • 6.2.1.2.3.1 Dissociation reagents can be enzymatic or non-enzymatic
        • 6.2.1.2.4 Balanced salt solutions
        • 6.2.1.2.4.1 Salt solutions find wide applications in life sciences
        • 6.2.1.2.5 Attachment & matrix factors
        • 6.2.1.2.5.1 Development of cells is dependent on attachment factors
        • 6.2.1.2.6 Antibiotics/Antimycotics
        • 6.2.1.2.6.1 Possibility of toxicity and contamination risks make long-term use of antibiotics/antimycotics conditional
        • 6.2.1.2.7 Contamination detection kits
        • 6.2.1.2.7.1 Kits provide results in hours, much faster than direct culture methods
        • 6.2.1.2.8 Cryoprotective reagents
        • 6.2.1.2.8.1 Inorganic expansions are a favored strategy for companies in this market
        • 6.2.1.2.9 Other cell culture reagents
      • 6.2.1.3 Sera
        • 6.2.1.3.1 Fetal bovine sera
        • 6.2.1.3.1.1 Use of FBS is associated with ethical issues
        • 6.2.1.3.2 Adult bovine sera
        • 6.2.1.3.2.1 ABS is used as a biochemical agent in IVD
        • 6.2.1.3.3 Other animal sera
    • 6.2.2 VESSELS
      • 6.2.2.1 Roller/roux bottles
        • 6.2.2.1.1 Roller bottles offer an economical means of cultivating large cell volumes
      • 6.2.2.2 Cell factory systems/cell stacks
        • 6.2.2.2.1 Cell stacks require special handling equipment and skilled expertise
      • 6.2.2.3 Multiwell plates
        • 6.2.2.3.1 Larger well formats allow for greater culture volumes
      • 6.2.2.4 Flasks
        • 6.2.2.4.1 Disposable flasks are in greater demand among end users
      • 6.2.2.5 Petri dishes
        • 6.2.2.5.1 Wide usage of Petri dishes is attributed to their ease of use
    • 6.2.3 BIOREACTOR ACCESSORIES
  • 6.3 EQUIPMENT
    • 6.3.1 SUPPORTING EQUIPMENT
      • 6.3.1.1 Filtration systems
        • 6.3.1.1.1 Growing research in cell biology is a key factor driving market growth
      • 6.3.1.2 Cell counters
        • 6.3.1.2.1 Automated cell counters are witnessing growing demand
      • 6.3.1.3 Carbon dioxide incubators
        • 6.3.1.3.1 Incubators provide control over atmospheric conditions for best effect
      • 6.3.1.4 Centrifuges
        • 6.3.1.4.1 Technological advances have enabled the development of faster, more effective centrifuges
      • 6.3.1.5 Autoclaves
        • 6.3.1.5.1 Autoclaves sterilize equipment and supplies for use
      • 6.3.1.6 Microscopes
        • 6.3.1.6.1 Inverted microscopes are widely used in cell culture processes
      • 6.3.1.7 Biosafety cabinets
        • 6.3.1.7.1 Cabinets are classified into three classes based on protection offered
      • 6.3.1.8 Other supporting equipment
    • 6.3.2 BIOREACTORS
      • 6.3.2.1 Conventional bioreactors
        • 6.3.2.1.1 Conventional bioreactors hold the largest share of the bioreactors market
      • 6.3.2.2 Single-use bioreactors
        • 6.3.2.2.1 Convenience, ease of use, and flexibility are driving demand for single-use bioreactors
    • 6.3.3 STORAGE EQUIPMENT
      • 6.3.3.1 Refrigerators & freezers
        • 6.3.3.1.1 Refrigerators & freezers are used for both short and long-term storage
      • 6.3.3.2 Cryostorage systems
        • 6.3.3.2.1 Benefits of long-term preservation of cell cultures are driving market growth

7 CELL CULTURE MARKET, BY APPLICATION

  • 7.1 INTRODUCTION
  • 7.2 BIOPHARMACEUTICAL PRODUCTION
    • 7.2.1 THERAPEUTIC PROTEINS
      • 7.2.1.1 Growing applications of recombinant proteins to drive this segment
    • 7.2.2 VACCINE PRODUCTION
      • 7.2.2.1 Rising incidence of disease outbreaks to drive the market for vaccine production
  • 7.3 DIAGNOSTICS
    • 7.3.1 CELL CULTURES ARE USED IN THE DIAGNOSIS OF VIRAL DISEASES
  • 7.4 DRUG SCREENING AND DEVELOPMENT
  • 7.5 STEM CELL RESEARCH
    • 7.5.1 STRINGENT REGULATIONS TO CONDUCT CLINICAL TRIALS FOR NEW STEM CELL-BASED THERAPIES ON HUMAN SUBJECTS IS RESTRAINING THE GROWTH OF THIS SEGMENT
  • 7.6 TISSUE ENGINEERING & REGENERATIVE MEDICINE
  • 7.7 OTHER APPLICATIONS

8 CELL CULTURE MARKET, BY END USER

  • 8.1 INTRODUCTION
  • 8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 8.2.1 INCREASING USE OF SINGLE-USE TECHNOLOGIES IS DRIVING THE GROWTH OF THE CELL CULTURE MARKET FOR THIS SEGMENT
  • 8.3 HOSPITALS AND DIAGNOSTIC LABORATORIES
    • 8.3.1 INCREASING AWARENESS FOR THE DIAGNOSIS OF VARIOUS DISEASES TO DRIVE THIS SEGMENT
  • 8.4 RESEARCH INSTITUTES
    • 8.4.1 INCREASING GOVERNMENT FUNDING FOR RESEARCH PROJECTS AND HIGH PREVALENCE OF CANCER TO DRIVE THE CELL CULTURE MARKET FOR RESEARCH INSTITUTES
  • 8.5 CELL BANKS
    • 8.5.1 INCREASING AWARENESS OF PRESERVING STEM CELLS TO DRIVE THIS SEGMENT

9 CELL CULTURE MARKET, BY REGION

  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA
    • 9.2.1 US
      • 9.2.1.1 US to dominate the North American cell culture market
    • 9.2.2 CANADA
      • 9.2.2.1 Advancement in the field of regenerative medicine to drive the cell culture market in Canada
  • 9.3 EUROPE
    • 9.3.1 GERMANY
      • 9.3.1.1 Increasing investment by various key players and growing funding from government organizations to drive the market
    • 9.3.2 FRANCE
      • 9.3.2.1 Support from government and private investors to drive the market for cell culture in France
    • 9.3.3 UK
      • 9.3.3.1 Growth in the life science industry to drive the market for cell culture in the UK
    • 9.3.4 ITALY
      • 9.3.4.1 Increasing number of cell biology seminars and conferences to fuel the adoption of cell culture products
    • 9.3.5 SPAIN
      • 9.3.5.1 Increasing funding from private and public organizations to aid market growth
    • 9.3.6 ROE
  • 9.4 ASIA PACIFIC
    • 9.4.1 JAPAN
      • 9.4.1.1 Strategic developments by companies to drive the market for cell culture in Japan
    • 9.4.2 CHINA
      • 9.4.2.1 Government initiatives and strategic initiatives by key players to strengthen the biotechnology industry in China
    • 9.4.3 INDIA
      • 9.4.3.1 Growth initiatives to promote life science industry to drive the market for cell culture in India
    • 9.4.4 ROAPAC
  • 9.5 REST OF THE WORLD (ROW)

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 MARKET SHARE ANALYSIS, 2018
  • 10.3 COMPETITIVE SCENARIO
    • 10.3.1 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS (2016-2019)
    • 10.3.2 PRODUCT LAUNCHES (2016-2019)
    • 10.3.3 EXPANSIONS (2016-2019)
    • 10.3.4 ACQUISITIONS (2016-2019)
  • 10.4 COMPETITIVE LEADERSHIP MAPPING (2019)
    • 10.4.1 VENDOR INCLUSION CRITERIA
    • 10.4.2 VANGUARDS
    • 10.4.3 INNOVATORS
    • 10.4.4 DYNAMIC PLAYERS
    • 10.4.5 EMERGING PLAYERS

11 COMPANY PROFILES

(Business Overview, Products Offered, Recent Developments, MnM View)*

  • 11.1 BECTON, DICKINSON AND COMPANY
  • 11.2 CELLGENIX
  • 11.3 CORNING
  • 11.4 DANAHER
  • 11.5 EPPENDORF
  • 11.6 FUJIFILM IRVINE SCIENTIFIC (ACQUIRED BY FUJIFILM CORPORATION)
  • 11.7 GE HEALTHCARE (A SUBSIDIARY OF GENERAL ELECTRIC COMPANY)
  • 11.8 HI-MEDIA LABORATORIES
  • 11.9 INVIVOGEN
  • 11.10 LONZA GROUP AG
  • 11.11 MERCK KGAA
  • 11.12 MILTENYI BIOTEC
  • 11.13 PROMOCELL
  • 11.14 SARTORIUS AG
  • 11.15 THERMO FISHER SCIENTIFIC

Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 INSIGHTS FROM INDUSTRY EXPERTS
  • 12.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 DISCUSSION GUIDE
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: APPROVED CELL CULTURE-BASED VACCINES FOR INFLUENZA
  • TABLE 2: APPROVED MONOCLONAL ANTIBODIES BY EMA/FDA FOR THERAPEUTIC USE
  • TABLE 3: GROWTH IN THE NUMBER OF PERSONALIZED MEDICINES
  • TABLE 4: CELL CULTURE MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 5: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 6: CELL CULTURE CONSUMABLES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 7: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 8: SERA, MEDIA, AND REAGENTS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 9: CELL CULTURE MEDIA MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 10: CELL CULTURE MEDIA MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 11: SERUM-FREE MEDIA MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 12: CLASSICAL MEDIA & SALTS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 13: STEM CELL CULTURE MEDIA MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 14: SPECIALTY MEDIA MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 15: CELL CULTURE REAGENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 16: CELL CULTURE REAGENTS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 17: SUPPLEMENTS AND GROWTH FACTORS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 18: BUFFERS & CHEMICALS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 19: CELL DISSOCIATION REAGENTS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 20: BALANCED SALT SOLUTIONS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 21: ATTACHMENT & MATRIX FACTORS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 22: ANTIBIOTICS/ANTIMYCOTICS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 23: CONTAMINATION DETECTION KITS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 24: CRYOPROTECTIVE REAGENTS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 25: OTHER CELL CULTURE REAGENTS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 26: CELL CULTURE SERA MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 27: CELL CULTURE SERA MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 28: FETAL BOVINE SERA MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 29: ADULT BOVINE SERA MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 30: OTHER ANIMAL SERA MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 31: VESSELS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 32: VESSELS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 33: ROLLER/ROUX BOTTLES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 34: CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 35: MULTIWELL PLATES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 36: FLASKS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 37: PETRI DISHES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 38: BIOREACTOR ACCESSORIES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 39: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 40: CELL CULTURE EQUIPMENT MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 41: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 42: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 43: FILTRATION SYSTEMS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 44: CELL COUNTERS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 45: CARBON DIOXIDE INCUBATORS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 46: CENTRIFUGES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 47: AUTOCLAVES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 48: MICROSCOPES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 49: BIOSAFETY CABINETS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 50: OTHER SUPPORTING EQUIPMENT MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 51: CELL CULTURE BIOREACTORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 52: CELL CULTURE BIOREACTORS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 53: CONVENTIONAL BIOREACTORS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 54: SINGLE-USE BIOREACTORS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 55: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 56: CELL CULTURE STORAGE EQUIPMENT MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 57: REFRIGERATORS & FREEZERS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 58: CRYOSTORAGE SYSTEMS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 59: CELL CULTURE MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 60: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 61: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 62: THERAPEUTIC PROTEINS MARKET, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 63: VACCINE PRODUCTION MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 64: CELL CULTURE MARKET FOR DIAGNOSTICS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 65: CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 66: CELL CULTURE MARKET FOR STEM CELL RESEARCH, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 67: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 68: CELL CULTURE MARKET FOR OTHER APPLICATIONS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 69: CELL CULTURE MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 70: CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 71: CELL CULTURE MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 72: CELL CULTURE MARKET FOR RESEARCH INSTITUTES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 73: CELL CULTURE MARKET FOR CELL BANKS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 74: CELL CULTURE MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 75: NORTH AMERICA: CELL CULTURE MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 76: NORTH AMERICA: CELL CULTURE MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 77: NORTH AMERICA: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 78: NORTH AMERICA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 79: NORTH AMERICA: CELL CULTURE MEDIA MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 80: NORTH AMERICA: CELL CULTURE REAGENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 81: NORTH AMERICA: CELL CULTURE SERA MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 82: NORTH AMERICA: CELL CULTURE VESSELS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 83: NORTH AMERICA: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 84: NORTH AMERICA: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 85: NORTH AMERICA: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 86: NORTH AMERICA: CELL CULTURE BIOREACTORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 87: NORTH AMERICA: CELL CULTURE MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 88: NORTH AMERICA: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 89: NORTH AMERICA: CELL CULTURE MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 90: US: CELL CULTURE MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 91: US: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 92: US: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 93: US: CELL CULTURE MEDIA MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 94: US: CELL CULTURE REAGENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 95: US: CELL CULTURE SERA MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 96: US: CELL CULTURE VESSELS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 97: US: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 98: US: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 99: US: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 100: US: CELL CULTURE BIOREACTORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 101: US: CELL CULTURE MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 102: US: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 103: US: CELL CULTURE MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 104: CANADA: CELL CULTURE MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 105: CANADA: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 106: CANADA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 107: CANADA: CELL CULTURE MEDIA MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 108: CANADA: CELL CULTURE REAGENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 109: CANADA: CELL CULTURE SERA MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 110: CANADA: CELL CULTURE VESSELS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 111: CANADA: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 112: CANADA: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 113: CANADA: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 114: CANADA: CELL CULTURE BIOREACTORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 115: CANADA: CELL CULTURE MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 116: CANADA: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 117: CANADA: CELL CULTURE MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 118: EUROPE: CELL CULTURE MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 119: EUROPE: CELL CULTURE MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 120: EUROPE: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 121: EUROPE: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 122: EUROPE: CELL CULTURE BIOREACTORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 123: EUROPE: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 124: EUROPE: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 125: EUROPE: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 126: EUROPE: CELL CULTURE MEDIA MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 127: EUROPE: CELL CULTURE REAGENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 128: EUROPE: CELL CULTURE SERA MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 129: EUROPE: CELL CULTURE VESSELS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 130: EUROPE: CELL CULTURE MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 131: EUROPE: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 132: EUROPE: CELL CULTURE MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 133: GERMANY: CELL CULTURE MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 134: GERMANY: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 135: GERMANY: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 136: GERMANY: CELL CULTURE MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 137: GERMANY: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 138: GERMANY: CELL CULTURE MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 139: FRANCE: CELL CULTURE MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 140: FRANCE: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 141: FRANCE: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 142: FRANCE: CELL CULTURE MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 143: FRANCE: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 144: FRANCE: CELL CULTURE MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 145: UK: CELL CULTURE MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 146: UK: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 147: UK: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 148: UK: CELL CULTURE MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 149: UK: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 150: UK: CELL CULTURE MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 151: ITALY: CELL CULTURE MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 152: ITALY: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 153: ITALY: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 154: ITALY: CELL CULTURE MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 155: ITALY: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 156: ITALY: CELL CULTURE MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 157: SPAIN: CELL CULTURE MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 158: SPAIN: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 159: SPAIN: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 160: SPAIN: CELL CULTURE MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 161: SPAIN: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 162: SPAIN: CELL CULTURE MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 163: ROE: CELL CULTURE MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 164: ROE: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 165: ROE: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 166: ROE: CELL CULTURE MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 167: ROE: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 168: ROE: CELL CULTURE MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 169: ASIA PACIFIC: CELL CULTURE MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 170: ASIA PACIFIC: CELL CULTURE MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 171: ASIA PACIFIC: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 172: ASIA PACIFIC: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 173: ASIA PACIFIC: CELL CULTURE MEDIA MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 174: ASIA PACIFIC: CELL CULTURE REAGENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 175: ASIA PACIFIC: CELL CULTURE SERA MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 176: ASIA PACIFIC: CELL CULTURE VESSELS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 177: ASIA PACIFIC: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 178: ASIA PACIFIC: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 179: ASIA PACIFIC: CELL CULTURE BIOREACTORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 180: ASIA PACIFIC: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 181: ASIA PACIFIC: CELL CULTURE MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 182: ASIA PACIFIC: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 183: ASIA PACIFIC: CELL CULTURE MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 184: JAPAN: CELL CULTURE MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 185: JAPAN: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 186: JAPAN: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 187: JAPAN: CELL CULTURE MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 188: JAPAN: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 189: JAPAN: CELL CULTURE MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 190: CHINA: CELL CULTURE MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 191: CHINA: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 192: CHINA: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 193: CHINA: CELL CULTURE MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 194: CHINA: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 195: CHINA: CELL CULTURE MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 196: INDIA: CELL CULTURE MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 197: INDIA: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 198: INDIA: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 199: INDIA: CELL CULTURE MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 200: INDIA: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 201: INDIA: CELL CULTURE MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 202: ROAPAC: CELL CULTURE MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 203: ROAPAC: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 204: ROAPAC: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 205: ROAPAC: CELL CULTURE MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 206: ROAPAC: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 207: ROAPAC: CELL CULTURE MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 208: ROW: CELL CULTURE MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 209: ROW: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 210: ROW: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 211: ROW: CELL CULTURE MEDIA MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 212: ROW: CELL CULTURE REAGENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 213: ROW: CELL CULTURE SERA MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 214: ROW: CELL CULTURE VESSELS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 215: ROW: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 216: ROW: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 217: ROW: CELL CULTURE BIOREACTORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 218: ROW: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 219: ROW: CELL CULTURE MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 220: ROW: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 221: ROW: CELL CULTURE MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 222: EXCHANGE RATES (USED FOR THE CONVERSION OF EURO TO USD)
  • TABLE 223: EXCHANGE RATES (USED FOR THE CONVERSION OF JPY YEN TO USD)
  • TABLE 224: EXCHANGE RATES (USED FOR THE CONVERSION OF EURO TO USD)

LIST OF FIGURES

  • FIGURE 1: CELL CULTURE MARKET
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4: MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
  • FIGURE 5: MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
  • FIGURE 6: DATA TRIANGULATION METHODOLOGY
  • FIGURE 7: CELL CULTURE MARKET, BY PRODUCT, 2019 VS. 2024 (USD BILLION)
  • FIGURE 8: CELL CULTURE MARKET, BY APPLICATION, 2019 VS. 2024 (USD BILLION)
  • FIGURE 9: CELL CULTURE MARKET, BY END USER (USD BILLION)
  • FIGURE 10: GEOGRAPHICAL SNAPSHOT: CELL CULTURE MARKET
  • FIGURE 11: CELL CULTURE MARKET TO WITNESS DOUBLE-DIGIT GROWTH RATE DURING THE FORECAST PERIOD
  • FIGURE 12: PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES COMMANDED THE LARGEST SHARE OF THE APAC CELL CULTURE MARKET IN 2019
  • FIGURE 13: CELL CULTURE MEDIA TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
  • FIGURE 14: THE BIOPHARMACEUTICAL PRODUCTION SEGMENT IS PROJECTED TO DOMINATE THE CELL CULTURE MARKET IN 2024
  • FIGURE 15: CONSUMABLES SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 16: ASIA PACIFIC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 17: CELL CULTURE MARKET: DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 18: CONSUMABLES SEGMENT TO DOMINATE THE CELL CULTURE PRODUCTS MARKET IN 2019
  • FIGURE 19: BIOPHARMACEUTICAL PRODUCTION SEGMENT TO DOMINATE MARKET DURING THE FORECAST PERIOD
  • FIGURE 20: PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES WILL CONTINUE TO DOMINATE THE CELL CULTURE MARKET IN 2024
  • FIGURE 21: NORTH AMERICA: CELL CULTURE MARKET SNAPSHOT
  • FIGURE 22: EUROPE: CELL CULTURE MARKET SNAPSHOT
  • FIGURE 23: ASIA PACIFIC: CELL CULTURE MARKET SNAPSHOT
  • FIGURE 24: REST OF THE WORLD (ROW): CELL CULTURE MARKET SNAPSHOT
  • FIGURE 25: KEY PLAYERS ADOPTED ORGANIC AS WELL AS INORGANIC GROWTH STRATEGIES BETWEEN 2016 AND 2019
  • FIGURE 26: MARKET EVOLUTION FRAMEWORK
  • FIGURE 27: GLOBAL CELL CULTURE MARKET SHARE ANALYSIS, BY KEY PLAYER, 2018
  • FIGURE 28: MNM DIVE-VENDOR COMPARISON MATRIX: CELL CULTURE MARKET
  • FIGURE 29: BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
  • FIGURE 30: CORNING: COMPANY SNAPSHOT
  • FIGURE 31: DANAHER: COMPANY SNAPSHOT
  • FIGURE 32: EPPENDORF: COMPANY SNAPSHOT
  • FIGURE 33: FUJIFILM CORPORATION: COMPANY SNAPSHOT
  • FIGURE 34: GENERAL ELECTRIC COMPANY: COMPANY SNAPSHOT
  • FIGURE 35: LONZA GROUP AG: COMPANY SNAPSHOT
  • FIGURE 36: MERCK KGAA: COMPANY SNAPSHOT
  • FIGURE 37: SARTORIUS AG: COMPANY SNAPSHOT
  • FIGURE 38: THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
Back to Top